{"result": "{\n    \"title\": \"Breast Cancer Research Community\",\n    \"summary\": \"The breast cancer research community revolves around a group of researchers who have made significant contributions to the field of breast cancer research. The community is centered around Cristofanilli M, a prominent researcher who has been involved in multiple studies on inflammatory breast cancer management and treatment. The community also includes other researchers who have co-authored studies with Cristofanilli M, such as Gonzalez-Angulo AM, Kau SW, Frye DK, Smith T, Wasaff B, Ibrahim N, Manikhas A, Gomez HL, Gladkov O, and Shao Z.\",\n    \"rating\": 6.5,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for the research to have a significant impact on the treatment and management of breast cancer.\",\n    \"findings\": [\n        {\n            \"summary\": \"Cristofanilli M's contributions to the community\",\n            \"explanation\": \"Cristofanilli M is a prominent researcher in the field of breast cancer research, with a focus on inflammatory breast cancer management and treatment. Cristofanilli M has been involved in multiple studies, including the GeparQuinto study, and has co-authored research papers with other researchers in the community. [Data: Entities (437), Relationships (239, 227, 277, +more)]\"\n        },\n        {\n            \"summary\": \"Co-authorship relationships within the community\",\n            \"explanation\": \"The community is characterized by co-authorship relationships between researchers, with Cristofanilli M being a central figure. The co-authorship relationships suggest a high level of collaboration and knowledge sharing within the community. [Data: Relationships (239, 227, 277, +more)]\"\n        },\n        {\n            \"summary\": \"Research focus on inflammatory breast cancer\",\n            \"explanation\": \"The community has a strong focus on inflammatory breast cancer, with multiple researchers having conducted studies on the topic. This suggests that the community is well-positioned to make significant contributions to the field of breast cancer research. [Data: Entities (437, 528, 529, +more)]\"\n        },\n        {\n            \"summary\": \"Collaboration with other researchers\",\n            \"explanation\": \"The community is characterized by collaboration between researchers, with multiple researchers having co-authored studies with Cristofanilli M. This suggests a high level of collaboration and knowledge sharing within the community. [Data: Relationships (239, 227, 277, +more)]\"\n        },\n        {\n            \"summary\": \"Impact of research on breast cancer treatment\",\n            \"explanation\": \"The research conducted by the community has the potential to have a significant impact on the treatment and management of breast cancer. The studies conducted by the community have shed light on the prognosis and treatment of inflammatory breast cancer, and have identified potential new targets for therapy. [Data: Entities (437, 528, 529, +more)]\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n437,\"\"\"CRISTOFANILLI M\"\"\",\"Here is a comprehensive summary of the data:\n\nCristofanilli M is a researcher who has made significant contributions to the field of inflammatory breast cancer management. Specifically, they conducted a study on inflammatory breast cancer management in the National Comprehensive Cancer Network. Additionally, they were involved in the GeparQuinto study, which further highlights their expertise in this area.\n\nCristofanilli M is also an author of several research papers and studies on inflammatory breast cancer. These publications include a study on breast cancer treatment, as well as studies on inflammatory breast cancer management, neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer, paclitaxel improving the prognosis in estrogen receptor negative inflammatory breast cancer, and the prognostic significance of HER-2 status in women with inflammatory breast cancer.\n\nOverall, Cristofanilli M is a prominent researcher in the field of inflammatory breast cancer, with a focus on management, treatment, and prognosis.\",18\r\n528,\"\"\"GONZALEZ-ANGULO AM\"\"\",\"\"\"Gonzalez-Angulo AM is an author of a study on paclitaxel improving the prognosis in estrogen receptor negative inflammatory breast cancer.\"\"\",1\r\n529,\"\"\"KAU SW\"\"\",\"Here is a comprehensive summary of the data:\n\nKau SW is a researcher who has made significant contributions to the field of breast cancer research. Specifically, Kau SW is an author of two studies that have shed light on the prognosis and treatment of inflammatory breast cancer. In one study, Kau SW investigated the impact of paclitaxel on the prognosis of estrogen receptor negative inflammatory breast cancer, demonstrating its potential to improve patient outcomes. In another study, Kau SW examined the prognostic significance of HER-2 status in women with inflammatory breast cancer, providing valuable insights into the role of this biomarker in predicting patient outcomes.\",1\r\n530,\"\"\"FRYE DK\"\"\",\"\"\"Frye DK is an author of a study on paclitaxel improving the prognosis in estrogen receptor negative inflammatory breast cancer.\"\"\",1\r\n536,\"\"\"SMITH T\"\"\",\"\"\"Smith T is an author of a study on breast cancer treatment.\"\"\",1\r\n537,\"\"\"WASAFF B\"\"\",\"\"\"Wasaff B is an author of a study on breast cancer treatment.\"\"\",1\r\n538,\"\"\"IBRAHIM N\"\"\",\"\"\"Ibrahim N is an author of a study on breast cancer treatment.\"\"\",1\r\n850,\"\"\"MANIKHAS A\"\"\",\"Here is a comprehensive summary of the data:\n\nManikhas A is a researcher who has made significant contributions to the field of breast cancer research. Specifically, Manikhas A has been involved in studies focused on HER2-positive advanced breast cancer, demonstrating expertise in this area. Additionally, Manikhas A has also authored a research paper on inflammatory breast cancer, further expanding their scope of research and expertise.\",1\r\n856,\"\"\"GOMEZ HL\"\"\",\"\"\"Gomez HL is a researcher involved in studies on HER2-positive advanced breast cancer.\"\"\",1\r\n851,\"\"\"GLADKOV O\"\"\",\"Here is a comprehensive summary of the data:\n\nGladkov O is a researcher who has been involved in studies on HER2-positive advanced breast cancer and inflammatory breast cancer. Specifically, Gladkov O is an author of a research paper on inflammatory breast cancer, and has also contributed to studies on HER2-positive advanced breast cancer.\n\nNote: I did not find any contradictions in the provided descriptions, so the summary is a straightforward concatenation of the information.\",1\r\n852,\"\"\"SHAO Z\"\"\",\"Here is a comprehensive summary of the data:\n\nShao Z is a researcher who has made significant contributions to the field of breast cancer research. Specifically, Shao Z has been involved in studies on HER2-positive advanced breast cancer, demonstrating their expertise in this area. Additionally, Shao Z has also authored a research paper on inflammatory breast cancer, further highlighting their breadth of knowledge and research experience in the field of breast cancer.\",1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\r\n239,\"\"\"GEPARQUINTO\"\"\",\"\"\"CRISTOFANILLI M\"\"\",\"\"\"Cristofanilli M is a researcher involved in the GeparQuinto study.\"\"\",39\r\n227,\"\"\"LAPATINIB\"\"\",\"\"\"CRISTOFANILLI M\"\"\",\"\"\"Cristofanilli M is an author of a research paper on a randomized phase II study of lapatinib plus pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer.\"\"\",30\r\n277,\"\"\"PAZOPANIB\"\"\",\"\"\"CRISTOFANILLI M\"\"\",\"\"\"Cristofanilli M is an author of a research paper on a randomized phase II study of lapatinib plus pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer.\"\"\",25\r\n353,\"\"\"MATRO JM\"\"\",\"\"\"CRISTOFANILLI M\"\"\",\"\"\"Matro JM and Cristofanilli M are co-authors of a study on inflammatory breast cancer management.\"\"\",23\r\n326,\"\"\"HORTOBAGYI GN\"\"\",\"\"\"CRISTOFANILLI M\"\"\",\"\"\"Cristofanilli M and Hortobagyi GN are co-authors of a study on paclitaxel improving the prognosis in estrogen receptor negative inflammatory breast cancer.\"\"\",22\r\n358,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"BUZDAR AU\"\"\",\"\"\"Cristofanilli M and Buzdar AU are co-authors of a study on paclitaxel improving the prognosis in estrogen receptor negative inflammatory breast cancer.\"\"\",21\r\n365,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"JOHNSTON SR\"\"\",\"\"\"Cristofanilli M and Johnston SR are co-authors of a study on HER2-positive advanced breast cancer.\"\"\",21\r\n361,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"SNEIGE N\"\"\",\"\"\"Cristofanilli M and Sneige N are co-authors of a study on breast cancer treatment.\"\"\",20\r\n357,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"GONZALEZ-ANGULO AM\"\"\",\"\"\"Cristofanilli M and Gonzalez-Angulo AM are co-authors of a study on paclitaxel improving the prognosis in estrogen receptor negative inflammatory breast cancer.\"\"\",19\r\n359,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"KAU SW\"\"\",\"\"\"Cristofanilli M and Kau SW are co-authors of a study on paclitaxel improving the prognosis in estrogen receptor negative inflammatory breast cancer.\"\"\",19\r\n360,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"FRYE DK\"\"\",\"\"\"Cristofanilli M and Frye DK are co-authors of a study on paclitaxel improving the prognosis in estrogen receptor negative inflammatory breast cancer.\"\"\",19\r\n362,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"SMITH T\"\"\",\"\"\"Cristofanilli M and Smith T are co-authors of a study on breast cancer treatment.\"\"\",19\r\n363,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"WASAFF B\"\"\",\"\"\"Cristofanilli M and Wasaff B are co-authors of a study on breast cancer treatment.\"\"\",19\r\n364,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"IBRAHIM N\"\"\",\"\"\"Cristofanilli M and Ibrahim N are co-authors of a study on breast cancer treatment.\"\"\",19\r\n366,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"MANIKHAS A\"\"\",\"\"\"Cristofanilli M and Manikhas A are co-authors of a study on HER2-positive advanced breast cancer.\"\"\",19\r\n367,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"GOMEZ HL\"\"\",\"\"\"Cristofanilli M and Gomez HL are co-authors of a study on HER2-positive advanced breast cancer.\"\"\",19\r\n368,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"GLADKOV O\"\"\",\"\"\"Cristofanilli M and Gladkov O are co-authors of a study on HER2-positive advanced breast cancer.\"\"\",19\r\n369,\"\"\"CRISTOFANILLI M\"\"\",\"\"\"SHAO Z\"\"\",\"\"\"Cristofanilli M and Shao Z are co-authors of a study on HER2-positive advanced breast cancer.\"\"\",19\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": null}}